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Ever since the Human Genome Project started to take shape in the late 1980s, social
inquiry has been concerned with the consequences of the renewed vigor and depth with
which biological knowledge has been shaping life itself. Kelly Happe’s book, The Material
Gene, carries forward this important set of concerns.
Happe sets out to draw out and critique the “political unconscious” of genomics
discourses as it manifests in current writing and practice in biomedicine, as well as
public and environmental health. Genomics’ political unconscious, so Happe’s key
argument goes, is hereditarianism: the cultural logic of the scientific concept of heredity.
Hereditarian ideology resides at genomic science’s cognitive core. Distinct from heredity,
hereditarianism is a political project in scientific clothing concerned with the continuation
of particular arrangements of social relations, cementing social and gender inequalities,
racism and environmental injustices.
After setting out this agenda, Happe proceeds to reveal the infusion of genomic discourse
with neoliberal ideology. She does so in three case studies all centrally concerned with
recent advances in genomic knowledge: genomics and the reproductive body, largely
centered on BRCA (breast cancer gene) testing and its consequences in the USA; genomics
and the racial body, dealing with reification of race in health disparities research; and
genomics and the polluted body, focusing on questions of environmental health, injustice,
and the rise of environmental genetics. While the three case studies are equally weighted
in terms of numbers of pages, her work on genetic testing for breast and ovarian cancer
in different populations of women not only provides the most empirical depth, but also
sets the stage for the other two case studies.
The book culminates in Happe’s overall evaluation of the material from the three cases,
which she reads to be an argument in favor of a biosociality without genes and perhaps
even without biology. She gives center stage to lived and embodied experiences, which
ought to be developing free of hereditarian discourses that fail to acknowledge the rich
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and diverse experiences of life as such and rather reproduce the neoliberal ideological
project to the continued and excessive disadvantage, particularly of black women.
Happe’s background is in rhetoric and communication. She draws heavily on feminist
critique and political economy and uses those to critically engage with social theorists
in the field of biomedicine. This explains three strengths about this thoughtful and
clearly written book: First, it is passionately written, fully committed to a political
agenda, and stringent in its argument to that effect. Second, it builds on an analysis of
discourse understood in rhetorical terms as the “transdisciplinary, institutional site for
mapping the overlapping interests of genomics and society” (p. 14). Third, it is “critical”
in the dialectic tradition of engagement and distant reflection. As such, the book is
an important contribution to scholarly critique in the field of biomedical and genomic
developments.
The strengths of this book are, however, also its weaknesses. The notion of discourse
offers little analytical grip. It is not firmly rooted in the Foucauldian notion of discourse
– probably most common in this field – but rather loosely aims at drawing out “interests”
from things written in and about the field of genomics. It provides the important link
to the concept of ideology, yet it does not help to situate the statements that Happe
analyses. We neither know how and why these statements were selected, nor do we learn
about their institutional or epistemic context. This is problematic, because the readers
are not given the knowledge to appreciate the social field of genomics and its dynamics.
Rather, readers need to put their trust in Happe’s selection and analysis.
This methodological weakness could be overlooked, yet it has analytical consequences.
All three case studies show how discourses of genomics, risk, and prevention interact
to reproduce a political project at the expense of (black) women’s lived experiences.
They do so through a breadth of examples from the scientific and popular press. In all
three cases, Happe produces a very homogeneous picture of what readers will know from
work over the last 20 years in science and technology studies, the sociology of health
and illness, and the anthropology of biomedicine, to be very heterogeneous fields. While
Happe briefly mentions alternative readings in and of the field(s), her analysis requires
the straw man of narrow reductionist and decontextualizing genomic science in order for
her switch to ideology and its critique to work.
Now, I do not want to belittle the importance of critical work on the interpellating
forces of genomic discourse. Some excellent pieces have been produced on inclusion
and diversity in medicine over the last decade or so. And Happe is certainly right in
stating that social and racial disparities and oppression continue throughout the twentieth
century and that genomics has become tied up in that not only in the US American
discourse. In that sense, it is important to pursue a critical reading. The question is by
what means.
Happe considers genomic risk a social construction and thus, in an early Butlerian
motion, bans everything genomic or biological from sites of agency for fear of reification
or naturalization. Instead, we are to trust social scientific knowledge about embodied
experiences as the less cruel reduction. I strongly feel that we moved on from this position
and the entrenchment of positivism and social constructivism. As Anna Tsing rightly
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states biology may no longer be the enemy of critical thought. Particular feminist analysis
of material–semiotic practices in medicine, care, and illness experiences have shown that
reality kicks back (see Karen Barad), that agency is distributed, that material bodies
resist some forms of enactment and not others and that careful critique is a matter
of generative and often comparative involvement (note Helen Verran and Annemarie
Mol). Anthropology and sociology alike have for some time argued for local biologies and
embedded bodies (discussed by Margaret Lock and myself), for a sociology of disease
(advocated by Stefan Timmermans) and for the detailed investigation of biomedical
platforms (as Alberto Cambrosio puts it) to understand biomedicalization (in Adele
Clarke and colleagues’ idiom) and the translation of laboratory knowledge into clinical
practice. Happe’s critique of Paul Rabinow and Nikolas Rose’s reading of biosociality as
underestimating the deeply political and unequal rather than enabling nature of genomics
discourse will certainly be shared by many in the field. Yet, it ignores the irony in
the original term biosociality and it also ignores that “another politics of life” (to echo
Didier Fassin) has become possible that gets closer to the heterogeneity of biomedical
discourse and practice and that also does not lose sight of “life as such” as the site of
care, empowerment, and interpellation. Regular readers of this journal will thus find
this book useful in its empirical material and will likely be sympathetic to the political
concerns, but might struggle with the analytical style.
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